Zeaxanthin for Skin & Brain

The eye is where zeaxanthin's evidence is strongest, but it is not the only place the body puts it. Carotenoids also deposit in the skin, where they contribute to the skin's own antioxidant defense, and in the brain, where lutein and zeaxanthin are among the dominant carotenoids in neural tissue. Both fields are genuinely interesting and both are, at this stage, more promising than proven. This page reviews the real human trials on skin photoprotection and on cognition — and is deliberately clear about where the science is still preliminary.

Table of Contents

1. Zeaxanthin Beyond the Eye
2. Carotenoids Accumulate in Skin
3. Skin Photoprotection: What Trials Show
4. Hydration, Elasticity and Appearance
5. Honest Limits on Skin Claims
6. The Brain Concentrates Lutein and Zeaxanthin
7. Macular Pigment and Cognition
8. The Cognitive Trials
9. Early Life: Infant Eyes and Brain
10. Honest Limits on Brain Claims
11. Key Research Papers
12. Connections
13. Featured Videos

Zeaxanthin Beyond the Eye

Once absorbed, zeaxanthin and lutein circulate in the blood on lipoproteins and are taken up by tissues throughout the body. Two non-ocular sites stand out because the pigments accumulate there in meaningful amounts and because there is a plausible biological reason for a benefit: the skin, our largest organ and our first barrier against ultraviolet light, and the brain, where these carotenoids are selectively enriched in gray matter. In both places the underlying logic is the same as in the eye — carotenoids are lipid-soluble antioxidants and light/oxidative-stress buffers — but the strength of evidence is a step below the ocular data.

Back to Table of Contents

Carotenoids Accumulate in Skin

Dietary carotenoids, including zeaxanthin and lutein, deposit in the skin, and skin carotenoid levels can be measured non-invasively (for example by resonance Raman spectroscopy) as a marker of fruit-and-vegetable intake. Studies comparing skin and blood levels (Meinke 2010) confirm that what you eat reaches the dermis and epidermis. Reviews of carotenoids in eye and skin health (Roberts 2009) describe how these pigments join vitamin E and other lipophilic antioxidants in the skin's defense network against reactive oxygen species generated by sunlight.

Back to Table of Contents

Skin Photoprotection: What Trials Show

The idea that dietary carotenoids can raise the skin's resistance to UV damage has real, if modest, experimental support:

• Carotenoids raise the threshold for UV-induced redness. A controlled human study (Heinrich 2003) found that supplementing beta-carotene or a comparable amount of mixed carotenoids increased the minimal erythema dose — the amount of UV needed to produce visible sunburn redness — over 12 weeks. Reviews by Stahl and Sies (2002) summarize the broader case that dietary carotenoids provide a measurable, systemic, but limited layer of photoprotection.
• Lutein and zeaxanthin specifically show effects. A double-blind, placebo-controlled study (Palombo 2007) using oral and/or topical lutein and zeaxanthin reported improvements in skin lipid peroxidation and photoprotective activity, with the combined oral-plus-topical approach performing best.
• A 2025 systematic review of oral photoprotection (Natarelli 2025) placed carotenoids among the dietary agents with the most supportive evidence, while emphasizing that the effect sizes are modest and that oral agents complement rather than replace sunscreen.

The consistent theme is that dietary carotenoids give the skin a small internal buffer against UV oxidative stress — useful and real, but far weaker than a topical sunscreen with a proper SPF.

Back to Table of Contents

Hydration, Elasticity and Appearance

Beyond sunburn thresholds, some small trials have looked at skin quality measures. The Palombo study (2007) reported improvements in skin hydration and elasticity as well as surface lipids with combined lutein/zeaxanthin treatment. A review of carotenoid skin-protective effects (Balic 2019) catalogs the mechanisms — antioxidant quenching, reduced lipid peroxidation, modulation of UV-induced inflammation — that could plausibly translate into better-appearing, better-protected skin over time.

These findings are encouraging for anyone hoping that a carotenoid-rich diet supports skin health, but they come from small studies, sometimes with a topical component and sometimes with commercial sponsorship, so they should be read as supportive rather than definitive. The most defensible claim is that a diet rich in colorful carotenoid-bearing vegetables is good for skin as part of overall antioxidant status — not that a zeaxanthin pill is a proven anti-aging or anti-wrinkle treatment.

Back to Table of Contents

Honest Limits on Skin Claims

• Not a sunscreen. The photoprotection is systemic and modest; it does not approach the protection of a topical SPF product and must not replace one.
• Small studies. Much of the skin data comes from small trials, some combining oral and topical carotenoids, which makes it hard to attribute effects to dietary zeaxanthin alone.
• Carotenodermia is cosmetic. Very high carotenoid intake can give skin a harmless orange-yellow tint; it is not toxicity and reverses with reduced intake.

Back to Table of Contents

The Brain Concentrates Lutein and Zeaxanthin

One of the more surprising discoveries of the last two decades is that the human brain selectively accumulates carotenoids — and that lutein and zeaxanthin, not the more abundant beta-carotene, are among the dominant ones in neural tissue. Analyses of human brain samples have found that lutein in particular is preferentially concentrated relative to its share of blood carotenoids, suggesting the brain actively takes it up. Because the retina is developmentally an outgrowth of the brain and uses the same pigments, macular pigment can serve as a convenient, measurable window onto brain carotenoid status.

A caveat worth stating up front: within the brain, lutein is generally the dominant of the two, with zeaxanthin present in smaller amounts. So brain research is largely a lutein-and-zeaxanthin story in which zeaxanthin is the junior partner — the reverse of the situation at the foveal center. For a fuller treatment of the cognitive research, see our companion Lutein Benefits pages.

Back to Table of Contents

Macular Pigment and Cognition

Because macular pigment reflects brain carotenoid status, researchers have asked whether people with denser macular pigment also perform better cognitively. Several observational studies say yes. Vishwanathan (2014) found that macular pigment optical density was related to cognitive function in older people; Renzi (2014) reported associations between macular pigment and cognition in both unimpaired and mildly cognitively impaired older adults; and Ajana (2018) and Kelly (2015) linked plasma lutein/zeaxanthin and macular pigment to cognitive performance. Johnson's foundational work (2012) first suggested a role for lutein and zeaxanthin in cognitive function in the elderly, later expanded into a lifespan review (Johnson 2014).

These are associations, and associations cannot prove that the carotenoids cause the better cognition — people who eat more leafy greens differ in many ways from those who do not. That is why the randomized trials matter.

Back to Table of Contents

The Cognitive Trials

A handful of randomized controlled trials have tested lutein and zeaxanthin supplementation on cognition, with modestly encouraging but not uniform results:

• Lindbergh 2018 — a randomized controlled trial reported that lutein and zeaxanthin supplementation influenced brain function in older adults, including changes in neural efficiency measured during cognitive tasks.
• Power 2018 — in a double-blind, placebo-controlled trial, supplemental retinal carotenoids enhanced memory in healthy individuals who started with low macular pigment, suggesting the people with the most to gain benefit most.
• Lopresti 2022 — a randomized, placebo-controlled study in adults with self-reported mild cognitive complaints found improvements in some cognitive measures with lutein/zeaxanthin supplementation.
• Parekh 2024 — extending the question to the young, a randomized trial reported improved dynamic visual and cognitive performance in children given lutein and zeaxanthin.

The overall picture is of small-to-moderate benefits in specific cognitive domains (memory, processing speed, neural efficiency), most evident in people starting from low carotenoid status. It is a promising and internally consistent body of work — but the effects are modest, the trials are relatively small, and none show that zeaxanthin prevents dementia.

Back to Table of Contents

Early Life: Infant Eyes and Brain

Lutein and zeaxanthin are present in breast milk and accumulate in the developing retina and brain, which has prompted interest in their role in early neural development. Overviews of pediatric carotenoid biology (Gazzolo 2021) describe lutein's accumulation in maturing eyes and brain, and primate studies (Jeon 2018) show that dietary lutein is deposited across specific brain regions differently depending on feeding. In premature infants, lutein and zeaxanthin have been studied for possible protection against retinopathy of prematurity; a 2025 Cochrane review (Choo 2025), however, concluded that the current evidence is insufficient to show a clear benefit on major outcomes in preterm infants — an honest reminder that biological plausibility does not guarantee clinical proof.

Back to Table of Contents

Honest Limits on Brain Claims

• Preliminary, not settled. Cognitive benefits are supported by several small RCTs and consistent observational data, but effect sizes are modest and long-term, dementia-relevant outcomes are unproven.
• Zeaxanthin is the minor brain carotenoid. Most brain and cognition work centers on lutein, with zeaxanthin along for the ride; do not over-attribute cognitive effects to zeaxanthin specifically.
• Combined supplements. Trials almost always give lutein and zeaxanthin together (sometimes with meso-zeaxanthin), so isolating zeaxanthin's contribution is not possible.
• No treatment claim. None of this supports using zeaxanthin to treat Alzheimer's disease or any dementia; see our Alzheimer's Disease page for evidence-based information.

Back to Table of Contents

Key Research Papers

1. Roberts RL, Green J, Lewis B (2009). Lutein and zeaxanthin in eye and skin health. Clinics in Dermatology. — PMID 19168000
2. Palombo P et al. (2007). Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin. Skin Pharmacology and Physiology. — PMID 17446716
3. Heinrich U et al. (2003). Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. Journal of Nutrition. — PMID 12514275
4. Stahl W, Sies H (2002). Carotenoids and protection against solar UV radiation. Skin Pharmacology and Applied Skin Physiology. — PMID 12239422
5. Meinke MC et al. (2010). Bioavailability of natural carotenoids in human skin compared to blood. European Journal of Pharmaceutics and Biopharmaceutics. — PMID 20558286
6. Johnson EJ et al. (2012). A possible role for lutein and zeaxanthin in cognitive function in the elderly. American Journal of Clinical Nutrition. — PMID 23053547
7. Lindbergh CA et al. (2018). Lutein and zeaxanthin influence brain function in older adults: a randomized controlled trial. Journal of the International Neuropsychological Society. — PMID 28695791
8. Power R et al. (2018). Supplemental retinal carotenoids enhance memory in healthy individuals with low levels of macular pigment: a randomized, double-blind, placebo-controlled trial. Journal of Alzheimer's Disease. — PMID 29332050
9. Lopresti AL et al. (2022). The effects of lutein and zeaxanthin supplementation on cognitive function in adults with self-reported mild cognitive complaints. Frontiers in Nutrition. — PMID 35252311
10. Vishwanathan R et al. (2014). Macular pigment optical density is related to cognitive function in older people. Age and Ageing. — PMID 24435852
11. Gazzolo D et al. (2021). Early pediatric benefit of lutein for maturing eyes and brain — an overview. Nutrients. — PMID 34579116
12. Choo YM et al. (2025). Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews. — PMID 40292760

PubMed Topic Searches

1. PubMed: Skin photoprotection
2. PubMed: Carotenoids and UV erythema
3. PubMed: L/Z and cognition
4. PubMed: Macular pigment and brain
5. PubMed: Brain carotenoid accumulation

External Resources

• Linus Pauling Institute — Carotenoids
• NIH Office of Dietary Supplements — Fact Sheets
• American Academy of Dermatology — Sun Protection

Back to Table of Contents

Connections

• Zeaxanthin (Main Page)
• Zeaxanthin Benefits Hub
• Zeaxanthin for Eye Health
• Zeaxanthin Food Sources
• Lutein (Brain-Dominant Partner)
• Lutein Benefits Hub
• Beta-Carotene
• Astaxanthin (Skin)
• Alzheimer's Disease
• All Neurology
• All Dermatology
• Vitamin C (Skin Antioxidant)
• Vitamin E (Skin Antioxidant)
• Eggs
• All Antioxidants

Back to Table of Contents

Featured Videos